134 related articles for article (PubMed ID: 9577175)
41. [Establishment of a quantitative method for detecting mixed chimerism using fluorescence-based PCR amplification of short tandem repeat markers after allogeneic hematopoietic stem cell transplantation in a Japanese population].
Saito A; Ogawa S; Mori S; Sakamaki H; Kami M; Miyakoshi J; Muto Y; Hatama T; Kawano M; Kinoshita M; Chiba S; Hirai H
Rinsho Ketsueki; 2002 May; 43(5):327-32. PubMed ID: 12096479
[No Abstract] [Full Text] [Related]
42. Minimal residual disease in hematologic disorders.
Faderl S; Kurzrock R; Estrov Z
Arch Pathol Lab Med; 1999 Nov; 123(11):1030-4. PubMed ID: 10539902
[TBL] [Abstract][Full Text] [Related]
43. Pattern of trisomy 1q in hematological malignancies: a single institution experience.
Djordjević V; Dencić-Fekete M; Jovanović J; Drakulić D; Stevanović M; Janković G; Gotić M
Cancer Genet Cytogenet; 2008 Oct; 186(1):12-8. PubMed ID: 18786437
[TBL] [Abstract][Full Text] [Related]
44. [Application of new FISH techniques for cytogenetic analysis in hematological malignancies].
Kakazu N; Abe T
Rinsho Ketsueki; 2002 May; 43(5):316-8. PubMed ID: 12096476
[No Abstract] [Full Text] [Related]
45. Clonal eosinophils are a morphologic hallmark of ETV6/ABL1 positive acute myeloid leukemia.
La Starza R; Trubia M; Testoni N; Ottaviani E; Belloni E; Crescenzi B; Martelli M; Flandrin G; Pelicci PG; Mecucci C
Haematologica; 2002 Aug; 87(8):789-94. PubMed ID: 12161353
[TBL] [Abstract][Full Text] [Related]
46. Genotypic analysis of esophageal squamous cell carcinoma by molecular cytogenetics and real-time quantitative polymerase chain reaction.
Yen CC; Chen YJ; Lu KH; Hsia JY; Chen JT; Hu CP; Chen PM; Liu JH; Chiou TJ; Wang WS; Yang MH; Chao TC; Lin CH
Int J Oncol; 2003 Oct; 23(4):871-81. PubMed ID: 12963965
[TBL] [Abstract][Full Text] [Related]
47. The role of fluorescence in situ hybridization (FISH) for monitoring hematologic malignancies with BCR/ABL or ETO/AML1 rearrangement: a comparative study with FISH and G-banding on 919 consecutive specimens of hematologic malignancies.
Lee DY; Cho HI; Kang YH; Yun SS; Park SY; Lee YS; Kim Y; Lee DS
Cancer Genet Cytogenet; 2004 Jul; 152(1):1-7. PubMed ID: 15193435
[TBL] [Abstract][Full Text] [Related]
48. Toward the validation of aneusomy detection by fluorescence in situ hybridization in bladder cancer: comparative analysis with cytology, cytogenetics, and clinical features predicts recurrence and defines clinical testing limitations.
Zhang FF; Arber DA; Wilson TG; Kawachi MH; Slovak ML
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2317-28. PubMed ID: 9815630
[TBL] [Abstract][Full Text] [Related]
49. Numerical aberrations of chromosome 8 detected by conventional cytogenetics and fluorescence in situ hybridization in individuals from northern Brazil with gastric adenocarcinoma.
Assumpção PP; Ishak G; Chen ES; Takeno SS; Leal MF; Guimarães AC; Calcagno DQ; Khayat AS; Demachki S; Smith Mde A; Burbano RR
Cancer Genet Cytogenet; 2006 Aug; 169(1):45-9. PubMed ID: 16875936
[TBL] [Abstract][Full Text] [Related]
50. Molecular cytogenetic aspects of hematological malignancies: clinical implications.
Chen Z; Sandberg AA
Am J Med Genet; 2002 Oct; 115(3):130-41. PubMed ID: 12407693
[TBL] [Abstract][Full Text] [Related]
51. FISH techniques.
Min T
Methods Mol Biol; 2003; 220():193-212. PubMed ID: 12744215
[No Abstract] [Full Text] [Related]
52. Usefulness of cytogenetics in leukemias.
VinSheth FJ; Sheth JJ; Patel AI; Shah AD; Verhest A
Indian J Cancer; 2002; 39(4):139-42. PubMed ID: 12928572
[TBL] [Abstract][Full Text] [Related]
53. Laser microdissection in hematopathology.
Fend F; Kremer M; Specht K; Quintanilla-Martinez L
Pathol Res Pract; 2003; 199(6):425-30. PubMed ID: 12924445
[No Abstract] [Full Text] [Related]
54. The proportion of clonal divisions varies in different hematologic malignancies. The United Kingdom Cancer Cytogenetics Group (UKCCG) [corrected].
Swansbury GJ
Cancer Genet Cytogenet; 1998 Jul; 104(2):139-45. PubMed ID: 9666808
[TBL] [Abstract][Full Text] [Related]
55. Molecular techniques in hematopathology.
Scarpa A; Achille A
Leuk Lymphoma; 1997 Dec; 26 Suppl 1():77-82. PubMed ID: 9570683
[TBL] [Abstract][Full Text] [Related]
56. [Fluorescence in situ hybridization in hematology].
Milosević I; Popović S; Urosević I
Vojnosanit Pregl; 2012 Nov; 69(11):986-93. PubMed ID: 23311251
[No Abstract] [Full Text] [Related]
57. Specific genetic defects as targets for selective therapies. Commentary.
Clarkson B
Curr Opin Hematol; 1994 Jul; 1(4):235-47. PubMed ID: 9371289
[No Abstract] [Full Text] [Related]
58. Molecular cytogenetic studies for hematological malignancies.
Dewald GW; Brockman SR; Paternoster SF
Cancer Treat Res; 2004; 121():69-112. PubMed ID: 15217207
[No Abstract] [Full Text] [Related]
59. ["Miguel F. Jiménez lecture. The paradigm of modern medicine: molecular genetics].
Benítez-Bribiesca L
Gac Med Mex; 1995; 131(2):197-203. PubMed ID: 8549907
[No Abstract] [Full Text] [Related]
60. [Molecular diagnostics].
Hino M
Nihon Rinsho; 2012 Apr; 70 Suppl 2():188-92. PubMed ID: 23133950
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
